お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
949574

オキシコドン医薬品市場:2019-2025年

Oxycodone Drug Market 2019-2025

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円
オキシコドン医薬品市場:2019-2025年
出版日: 2020年06月12日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のオキシコドン医薬品市場は、予測期間中、大幅な成長が見込まれています。癌やHIVなどの末期疾患の頻度の増加および術後疼痛処方薬の急増により、世界のオキシコドン薬市場の成長が促進されています。新薬の開発は、オキシコドン市場の大きな市場機会です。Oxycontin と Opanaで行われる乱用防止製剤など、製剤・薬物設計に革新をもたらす新製品は、ブランド薬の鎮静剤市場を活性化します。さらに、米国食品医薬品局 (FDA) は、中毒性の少ない新世代の医薬品を提案するよう医薬品企業に働きかけています。

当レポートでは、世界のオキシコドン医薬品市場について調査分析し、市場概要、市場成長への影響要因、市場規模と予測、セグメント別の市場分析、地域・国別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要および考察

  • 調査範囲
  • アナリストの考察&現在の市場動向

第3章 競合情勢

  • 企業シェア分析
  • 主要戦略分析
  • 主要企業分析
    • Purdue Pharma L.P
    • Janssen Pharmaceuticals, Inc. (A Johnson & Johnson Subsidiary)
    • Hikma Pharmaceuticals USA, Inc.
    • Pfizer, Inc.
    • Sanofi-Aventis S.A.

第4章 市場決定要因

  • 促進要因
  • 抑制要因
  • 機会

第5章 市場セグメンテーション

  • 世界のオキシコドン医薬品市場:用途別
    • 疼痛管理
    • 麻酔
    • 中毒管理

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • その他アジア太平洋地域
  • その他の地域

第7章 企業プロファイル

  • Allergan PLC
  • Endo Pharmaceuticals, Inc.
  • Grunenthal GmbH
  • Hikma Pharmaceuticals USA, Inc.
  • Janssen Pharmaceuticals, Inc. (A Johnson & Johnson Subsidiary)
  • Pfizer, Inc.
  • Purdue Pharma L.P
  • Sanofi-Aventis S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Vistapharm Inc.
図表

LIST OF TABLES

  • 1. GLOBAL OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 2. GLOBAL OXYCODONE DRUG FOR PAIN MANAGEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL OXYCODONE DRUG FOR ANESTHESIA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL OXYCODONE DRUG FOR ADDICTION MANAGEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBALOXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 7. NORTH AMERICAN OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 8. NORTH AMERICAN OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 9. EUROPEAN OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 10. EUROPEAN OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 11. ASIA-PACIFIC OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 12. ASIA-PACIFIC OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 13. REST OF THE WORLD OXYCODONE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL OXYCODONE DRUG MARKET SHARE BY TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL OXYCODONE DRUG MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
  • 3. GLOBAL OXYCODONE DRUG MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD OXYCODONE DRUG MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2021893

Global Oxycodone Drug Market Size, Share & Trends Analysis Report, by Applications (Pain Management, Anesthesia, and Addiction Management), and Forecast Period 2019-2025

The global oxycodone drug market is estimated to grow at a significant CAGR during the forecast period. The increasing frequency of terminally ill diseases such as cancer and HIV and a high surge in post-operative pain prescribed medication is driving the growth of the global oxycodone drug market.New drug development is a large market opportunity for the oxycodone market. New products with innovations in formulations and drug designing such as abuse-deterrent formulations done in Oxycontin and Opana, fuel the branded opiate market. Moreover, the US Food and Drug Administration is also encouraging drug makers to come up with a new generation drug that is less addictive.

An increase in new drug applications by pharmaceutical companies and the number of products in the pipeline drives the future opportunity growth of the global oxycodone market. Other formulations such as control release of drugs for improved pain management are coming up in the market. Advanced drug formulations such as extended-release medications for pain control are examples of improved formulation driving the market.

The global oxycodone market is segmented into applications into pain management, anesthesia, and de-addiction. Pain management accounts for the largest market portion, owing to the increasing frequency of Parkinson's syndrome, rheumatic, and cancer patients. Geographically, theglobal oxycodone drugs market is segmented based on the region including North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

The major manufactures of the oxycodone drug include Purdue Pharma L.P, Janssen Pharmaceuticals (A Johnson & Johnson Subsidiary), Inc., Hikma Pharmaceuticals USA, Inc., Pfizer, Inc., Sanofi-Aventis S.A., Sun Pharmaceutical Industries Ltd., and others. The range of oxycodone drugs provided by these companies is Oxynorm, OxyContin, Endone, Proladone, Targin, and more. These companies are receiving approvals for new drugs that are expected to contribute to the oxycodone drug market. For instance, in April 2017, the FDA approved RoxyBond, a new formulation of immediate-release oxycodone. This oxycodone formulation is the first immediate-release opioid analgesic approved with labeling describing its abuse-deterrent properties.

Research Methodology

The market study of the global oxycodone drugs market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Reports of companies involved in the market
  • Authentic Public Databases
  • Whitepapers such as research papers and news blogs
  • Company websites and their product catalog

The report is intended for providers, suppliers, and distributors of fiberglass, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and will serve as a source for 360-degree analysis of the market.

Market Segmentation-

  • Global Oxycodone Drugs Market by Type
  • Global Oxycodone Drugs Market by Application

The Report Covers:

  • Comprehensive research methodology of the global oxycodone drug market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Insights about market determinants which are stimulating the global oxycodone drugs market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusions

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Purdue Pharma L.P
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Janssen Pharmaceuticals, Inc. (A Johnson & Johnson Subsidiary)
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Hikma Pharmaceuticals USA, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Pfizer, Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Sanofi-Aventis S.A.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Oxycodone Drug Market byApplication
    • 5.1.1. Pain Management
    • 5.1.2. Anesthesia
    • 5.1.3. Addiction Management

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Allergan PLC
  • 7.2. Endo Pharmaceuticals, Inc.
  • 7.3. Grunenthal GmbH
  • 7.4. Hikma Pharmaceuticals USA, Inc.
  • 7.5. Janssen Pharmaceuticals, Inc. (A Johnson & Johnson Subsidiary)
  • 7.6. Pfizer, Inc.
  • 7.7. Purdue Pharma L.P
  • 7.8. Sanofi-Aventis S.A.
  • 7.9. Sun Pharmaceutical Industries Ltd.
  • 7.10. Teva Pharmaceutical Industries Ltd.
  • 7.11. Vistapharm Inc.
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.